Use of Complementary and Alternative Medicine Among Females with Polycystic Ovary Syndrome in Jordan: a Cross-sectional Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Dec 24

PMID 39719295

Authors

Oriana Awwad

Mais Saleh

Sana Bardaweel

Ali Alsamydai

Fatma U Afifi

Amal Akour

Renad Abu Tarboosh

Manar Hamdan

Asma Sad Basha

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Polycystic ovary syndrome (PCOS) is a prevalent female reproductive and metabolic disorder. Among patients with chronic conditions, an increasing number have approached complementary and alternative medicine (CAM) to cope with their disease. This study aimed to assess the use of CAM among females with PCOS in Jordan.

Design, Settings And Participants: A cross-sectional study was conducted at one of the largest tertiary centres in Jordan. Adult females with PCOS were interviewed using a data collection tool.

Outcome Measures: CAM use and the factors associated with its use.

Results: A total of 402 women participated in the study, the median-IQR age was 25 (31-21) years. Common PCOS signs/symptoms included menses irregularity (81.8%), fatigue (71.6%) and hyperandrogenism (77.6%). Among all participants, 63.2% used CAM with the most common being herbs (60.4%). The primary sources of information were family and friends (46.1%).Longer duration since diagnosis, having more PCOS signs/symptoms and a higher level of education were factors significantly associated with CAM use (=1.257, 95% CI=1.018 to 2.552, p=0.034; =1.146, 95% CI=1.052 to 1.250, p=0.002 and =1.584, 95% CI=1.054 to 2.379, p=0.027, respectively). Of all the CAM users, 57.5% reported an amelioration in PCOS symptoms; this was significantly associated with the long-term use of CAM (=12.759, 95% CI=6.789 to 23.976, p<0.001). Just a few participants (9.4%) reported side effects.

Conclusion: A variety of CAM approaches were reported by the study population; herbs were the most widely used and accepted by the patients. Considering the primary source of information and the potential interactions of herbal medicine with the standard PCOS treatment, efforts are needed by healthcare providers to better understand the use of CAM among their patients with PCOS.

References

Shoorei H, Banimohammad M, Kebria M, Afshar M, Taheri M, Shokoohi M . Hesperidin improves the follicular development in 3D culture of isolated preantral ovarian follicles of mice. Exp Biol Med (Maywood). 2019; 244(5):352-361. PMC: 6488865. DOI: 10.1177/1535370219831615. View

Alhussain F, AlRuthia Y, Al-Mandeel H, Bellahwal A, Alharbi F, Almogbel Y . Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program. Patient Prefer Adherence. 2020; 14:737-746. PMC: 7167265. DOI: 10.2147/PPA.S244273. View

Bari S, Chineke I, Darwin A, Umar A, Jim H, Muzaffar J . Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population. Integr Cancer Ther. 2021; 20:15347354211051622. PMC: 8724982. DOI: 10.1177/15347354211051622. View

Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei M . Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis. J Ethnopharmacol. 2020; 254:112741. DOI: 10.1016/j.jep.2020.112741. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

Fjaer E, Landet E, McNamara C, Eikemo T . The use of complementary and alternative medicine (CAM) in Europe. BMC Complement Med Ther. 2020; 20(1):108. PMC: 7137515. DOI: 10.1186/s12906-020-02903-w. View

Haj-Husein I, Tukan S, Alkazaleh F . The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study. J Hum Nutr Diet. 2015; 29(1):105-11. DOI: 10.1111/jhn.12290. View

Butler A, Abouseif A, Dargham S, Sathyapalan T, Atkin S . Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations. Sci Rep. 2020; 10(1):18895. PMC: 7641235. DOI: 10.1038/s41598-020-75109-2. View

Mbizo J, Okafor A, Sutton M, Leyva B, Stone L, Olaku O . Complementary and alternative medicine use among persons with multiple chronic conditions: results from the 2012 National Health Interview Survey. BMC Complement Altern Med. 2018; 18(1):281. PMC: 6194645. DOI: 10.1186/s12906-018-2342-2. View

10.

Wazaify M, AlAwwa I, Yasein N, Al-Saleh A, Afifi F . Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract. 2013; 19(3):153-7. DOI: 10.1016/j.ctcp.2013.03.001. View

11.

Raja-Khan N, Stener-Victorin E, Wu X, Legro R . The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2011; 301(1):E1-E10. PMC: 4459923. DOI: 10.1152/ajpendo.00667.2010. View

12.

Kotlyar A, Seifer D . Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes. Reprod Biol Endocrinol. 2023; 21(1):70. PMC: 10391774. DOI: 10.1186/s12958-023-01120-7. View

13.

Santibanez M, Garrastazu R, Ruiz-Nunez M, Helguera J, Arenal S, Bonnardeux C . Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease. PLoS One. 2016; 11(6):e0158727. PMC: 4928940. DOI: 10.1371/journal.pone.0158727. View

14.

Mesraoua B, Kissani N, Deleu D, Elsheikh L, Ali M, Melikyan G . Complementary and alternative medicine (CAM) for epilepsy treatment in the Middle East and North Africa (MENA) region. Epilepsy Res. 2021; 170:106538. DOI: 10.1016/j.eplepsyres.2020.106538. View

15.

Celik O, Kose M . An overview of polycystic ovary syndrome in aging women. J Turk Ger Gynecol Assoc. 2021; 22(4):326-333. PMC: 8666998. DOI: 10.4274/jtgga.galenos.2021.2021.0077. View

16.

Akour A, Bardaweel S, Awwad O, Al-Muhaissen S, Hussein R . Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study. Eur J Contracept Reprod Health Care. 2018; 22(6):459-464. DOI: 10.1080/13625187.2017.1412425. View

17.

Zeng X, Xie Y, Liu Y, Long S, Mo Z . Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019; 502:214-221. DOI: 10.1016/j.cca.2019.11.003. View

18.

Manouchehri A, Abbaszadeh S, Ahmadi M, Khajoei Nejad F, Bahmani M, Dastyar N . Polycystic ovaries and herbal remedies: A systematic review. JBRA Assist Reprod. 2022; 27(1):85-91. PMC: 10065776. DOI: 10.5935/1518-0557.20220024. View

19.

Feyzollahi Z, Kouchesfehani H, Jalali H, Eslimi-Esfahani D, Sheikh Hosseini A . Effect of ethanolic extract on hypothalamic gene expression in a rat model of polycystic ovary syndrome. Avicenna J Phytomed. 2021; 11(3):292-301. PMC: 8140208. View

20.

Edwards E . The role of complementary, alternative, and integrative medicine in personalized health care. Neuropsychopharmacology. 2011; 37(1):293-5. PMC: 3238094. DOI: 10.1038/npp.2011.92. View